2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2022-12-17±³À°ÀÏÀÚ : 2022-12-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º ¿ÀÅ°µå·ë ¿Ü 1°³·ë
±³À°ÁÖÁ¦ :
2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½É±Ù°æ»ö¿¬±¸È¸
´ã´çÀÚ : ¹Ú¹Ì°æ
¿¬¶ôó : 062-220-4227
À̸ÞÀÏ :
myocardial-mr@daum.net ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-17 Orchid Room 08:30~08:40 Viability Test is not Viable!!, Just CABG It!! ¼Á¸(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12-17 Orchid Room 08:40~08:50 Viability Test is Still Viable!! Á¶ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-17 Orchid Room 08:50~09:00 Optimal medical therapy is the Key; ARNI, SGLT2 Inhibitor, and so on À±Á¾Âù(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-17 Orchid Room 09:00~09:10 PCI should be REVIVED for Patients with ischemic cardiomyopathy ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë)
Åä·Ð 12-17 09:10~09:30 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Camellia Room 08:30~08:40 Case 1: My first night in cath lab on call ÀüÈ£¼º(¿øÁÖ¼¼ºê¶õ½º)
Åä·Ð 12-17 08:40~08:50 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Camellia Room 08:50~09:00 Case 2: AMI with unusual coronary artery dissection and large thrombus burden À±Àç¿ë(±¸¹ÌÂ÷º´¿ø)
Åä·Ð 12-17 09:00~09:10 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Camellia Room 09:10~09:20 Case 3: Treating AMI with Ambiguous Lesion: Which One is Culprit Lesion? Ȳµµ¿¬(¼¿ïÀÇ´ë)
Åä·Ð 12-17 09:20~09:30 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 09:30~09:40 FRAME-AMI: FFR versus angiography-guided PCI in AMI with multivessel disease ÇÑÁÖ¿ë(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 12-17 Camellia Room 09:30~09:40 Case 1: AMI Patients with severe LV dysfunction: Revascularization or medical therapy ±âÀ¯Á¤(°æÈñÀÇ´ë)
Åä·Ð 12-17 09:40~09:50 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 09:50~10:00 PACIFIC-AMI: Factor XIa inhibitor asundexian on top of DAPT after AMI ¹Ú¿ëÈÖ(°æ»óÀÇ´ë)
±³À°½Ã°£ 12-17 Camellia Room 09:50~10:00 Case 2: Elderly patients with cardiogenic shock requring mechanical circulatory support: ethics and evidence Àå¿ìÁø(ÀÌÈ¿©´ë)
Åä·Ð 12-17 10:00~10:10 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 10:10~10:20 BOX: how to optimize oxygen therapy and blood pressure in post-resuscitation care ¿øÈ£¿¬(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 12-17 Camellia Room 10:10~10:20 Case 3: AMI Patients with high bleeding risk and complex lesion ±è³²±Õ(°æºÏÀÇ´ë)
Åä·Ð 12-17 10:20~10:30 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 12-17 10:30~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 12-17 Orchid Room 11:00~11:10 What to do if you question cardiac troponin values in acute and emergency setting? À±¿µÁø(¿øÁÖ¼¼ºê¶õ½º)
±³À°½Ã°£ 12-17 Camellia Room 11:00~11:10 Case 1: Never Treat the Non-Culprit in the Same Setting !!! ÀÌÁöÇö(ÇѾçÀÇ´ë)
Åä·Ð 12-17 11:10~11:20 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 11:20~11:30 Periprocedural MI: is there a right definition and clinical significance? ¹ÚÁö¿µ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 12-17 Camellia Room 11:20~11:30 Case 2: Fix it All As Many As You Can in the Same Setting !!! Â÷Á¤ÁØ(°í·ÁÀÇ´ë)
Åä·Ð 12-17 11:30~11:40 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 11:40~11:50 How to evaluate COVID-19 patients with myocardial injury ¹®Àαâ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12-17 Camellia Room 11:40~11:50 Case 3: One Stage Multivessel PCI in Patients with cardiogenic shock under hemodynamic support ÀÓ¿ëȯ(Àü³²ÀÇ´ë)
Åä·Ð 12-17 11:50~12:00 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±âŸ 12-17 Orchid Room 12:00~12:10 WeKnew ¼Ò°³, ÄÁÅÙÃ÷ ½Ã¿¬ ¹× MOU ü°á½Ä Ȳº¸À²(À§´º)
±³À°½Ã°£ 12-17 Orchid Room 12:10~12:25 Earlier & Longer is Better!- Clinical Benefits of Evolocumab in ACS À̽ÂÇå(Àü³²ÀÇ´ë)
±³À°½Ã°£ 12-17 Orchid Room 12:25~12:40 Optimal comorbidity management for CV protection in hypertensive patients with dyslipidemia È«¼øÁØ(°í·ÁÀÇ´ë)
½Ä»ç 12-17 12:40~13:00 ½Ä»ç ()
±³À°½Ã°£ 12-17 Orchid Room 13:00~13:10 Do the clinical study results support the use of EMCO and Impella rather than IABP in cardiogenic shock? ±è¿õ(¿µ³²ÀÇ´ë)
Åä·Ð 12-17 13:10~13:20 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 13:20~13:30 Do you prefer culprit-only PCI? If then, how can you detect culprit lesion in multivessel disease? ±è¹Îö(Àü³²ÀÇ´ë)
Åä·Ð 12-17 13:30~13:40 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 13:40~13:50 How to transition from ECMO to heart transplantation? ±èÁ¤¼ö(ºÎ»êÀÇ´ë)
Åä·Ð 12-17 13:50~14:00 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-17 Orchid Room 14:00~14:20 ½ÉÇ÷°ü°è ÇʼöÀÇ·áÁ¤Ã¥ ¹æ¾È ±èÇѼ÷(Áúº´Á¤Ã¥°úÀå)
±³À°½Ã°£ 12-17 Orchid Room 14:20~14:40 ½ÉÀå³»°ú Àǻ簡 »ý°¢ÇÏ´Â ÇʼöÀÇ·áÁ¤Ã¥ ¹æÇâ °ÇöÀç(¼¿ïÀÇ´ë)
Åä·Ð 12-17 14:40~15:00 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 12-17 15:00~15:20 ÈÞ½Ä ()
±³À°½Ã°£ 12-17 Orchid Room 15:20~15:35 Current trend of developing clinical practice guideline ¹Úµ¿¾Æ(Çѱ¹º¸°ÇÀǷῬ±¸¿ø)
±³À°½Ã°£ 12-17 Orchid Room 15:35~15:50 What we have done for Korean guideline of myocardial infarction ±èÇö±¹(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 12-17 Orchid Room 15:50~16:05 Gap between real practice and guideline in AMI: insight from survey for lipid management ÀÌ»ó¿±(Áß¾ÓÀÇ´ë)